Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.

Bone marrow transplantation - 1 Feb 2025

Gui Gege, Ravindra Niveditha, Hegde Pranay S, Andrew Georgia, Mukherjee Devdeep, Wong Zoë, Auletta Jeffery J, El Chaer Firas, Chen Evan C, Chen Yi-Bin, Corner Adam, Devine Steven M, Iyer Sunil G, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Spellman Stephen R, Zeger Scott L, Page Kristin M, Dillon Laura W, Hourigan Christopher S

Abstract excerpt

Routine genetic profiling of acute myeloid leukemia (AML) at initial diagnosis has allowed subgroup specific prognostication, drug development, and clinical management strategies. The optimal approach for treatment response assessment for AML subgroups has not yet however been determined. A nationwide cohort of 257 adult patients in first remission (CR1) from AML associated with an IDH2 mutation (IDH2m)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Leukemia, Myeloid, Acute

Share to Neoplasm, Residual

Share to Nucleophosmin

Share to Transplantation, Homologous

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39455897
DOI: 10.1038/s41409-024-02449-2
PMCID: PMC11810785

Genes

CR1
IDH2
FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.PMID 39455897Read ↗

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.Semantic proximity Read ↗

Measurable Residual<i>IDH1</i>before Allogeneic Transplant for Acute Myeloid LeukemiaSemantic proximity Read ↗

Pre-MEASURE:<i>FLT3</i>-ITD and mutated<i>NPM1</i>measurable residual disease before allogeneic transplant in adults with AML in first remissionSemantic proximity Read ↗

Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation.Semantic proximity Read ↗

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.Semantic proximity Read ↗

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemiaSemantic proximity Read ↗

Persistent<i>IDH</i>mutations are not associated with increased relapse or death in patients with<i>IDH</i>-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideSemantic proximity Read ↗

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia.Semantic proximity Read ↗

Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development.Semantic proximity Read ↗

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.Semantic proximity Read ↗

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.Semantic proximity Read ↗

IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.